论文信息 - CTLA-4 overexpression in CD19+/CD5+ cells correlates with the level of cell cycle regulators and disease progression in B-CLL patients - 字舞流文

CTLA-4 overexpression in CD19+/CD5+ cells correlates with the level of cell cycle regulators and disease progression in B-CLL patients

I. Frydecka | A. Kosmaczewska | L. Ciszak | D. Wołowiec | K. Suwalska

[1] L. Polito,et al. CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells. , 2003, Blood.

[2] R. Pirskanen,et al. Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence , 2002, Journal of Neuroimmunology.

[3] M. Jeddi-Tehrani,et al. Intracellular T cell cytokines in patients with B cell chronic lymphocytic leukaemia (B‐CLL) , 2002, European journal of haematology.

[4] A. Sharpe,et al. CTLA‐4 regulates cell cycle progression during a primary immune response , 2002, European journal of immunology.

[5] J. Hillert,et al. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms , 2001, Genes and Immunity.

[6] K. Kuliczkowski,et al. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia. , 2001, Haematologica.

[7] J. Allison,et al. CTLA-4-Mediated inhibition of early events of T cell proliferation. , 1999, Journal of immunology.